Clinical Trial Update: Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating nitric oxide administration during pediatric cardiopulmonary bypass to prevent platelet activation has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Platelet Dysfunction

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Inflammation, Platelet Dysfunction | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-08-13